Oric Pharmaceuticals

-$0.08 (-2.47%) As of 6:26 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ORIC and other ETFs, options, and stocks.

About ORIC

Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology.

CEO
Jacob M. Chacko
Employees
78
Headquarters
South San Francisco, California
Founded
2014

ORIC Key Statistics

Market cap
124.75M
Price-Earnings ratio
—
Dividend yield
—
Average volume
423.59K
High today
$3.27
Low today
$3.14
Open price
$3.22
Volume
129.61K
52 Week high
$26.70
52 Week low
$2.62

ORIC Earnings

-$0.84
-$0.56
-$0.28
-$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure